China Biotech Services Holdings (HKSE:08037) Other Current Payables : HK$18.40 Mil (As of Dec. 2024)

View and export this data going back to 2004. Start your Free Trial

What is China Biotech Services Holdings Other Current Payables?

China Biotech Services Holdings's Other Current Payables for the quarter that ended in Dec. 2024 was HK$18.40 Mil.

China Biotech Services Holdings's quarterly Other Current Payables declined from Dec. 2023 (HK$27.83 Mil) to Jun. 2024 (HK$21.14 Mil) and declined from Jun. 2024 (HK$21.14 Mil) to Dec. 2024 (HK$18.40 Mil).

China Biotech Services Holdings's annual Other Current Payables increased from Dec. 2022 (HK$6.07 Mil) to Dec. 2023 (HK$27.83 Mil) but then declined from Dec. 2023 (HK$27.83 Mil) to Dec. 2024 (HK$18.40 Mil).

China Biotech Services Holdings Other Current Payables Historical Data

The historical data trend for China Biotech Services Holdings's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Biotech Services Holdings Other Current Payables Chart

China Biotech Services Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Current Payables

Get a 7-Day Free Trial

9.77

10.31

6.07

27.83

18.40

China Biotech Services Holdings Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Dec24
Other Current Payables	Get a 7-Day Free Trial															13.03	-	27.83	21.14	18.40

China Biotech Services Holdings Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

China Biotech Services Holdings Other Current Payables Related Terms

Thank you for viewing the detailed overview of China Biotech Services Holdings's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

China Biotech Services Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » China Biotech Services Holdings Ltd (HKSE:08037) » Definitions » Other Current Payables

Comparable Companies

Traded in Other Exchanges

N/A

Address

255-257 Gloucester Roaad, Suites 1904-05A, 19th Floor, Sino Plaza, Causeway Bay, Hong Kong, HKG

Website

http://www.cbshhk.com

China Biotech Services Holdings Ltd is an investment holding company. It operates through six segments: Pharmaceutical Products, Medical and Health-Related Services, Immunotherapy, Securities, Insurance brokerage, BNCT and Others. It derives prime revenue from the Medical and health related services segment which involves the provision of medical laboratory testing and health check services. The group has a business presence in Hong Kong and the PRC, of which key revenue is generated from Hong Kong.

Executives

Guoyuan International Holdings Limited	2201 Interest of corporation controlled by you
Guoyuan Securities Co., Ltd.	2201 Interest of corporation controlled by you
Guoyuan Securities Investment (hong Kong) Limited	2101 Beneficial owner
Genius Earn Limited	2201 Interest of corporation controlled by you
Genius Lead Limited	2101 Beneficial owner
Liu Xiaolin	2101 Beneficial owner
Richlane Ventures Limited	2101 Beneficial owner
Ko Chun Shun, Johnson	2201 Interest of corporation controlled by you

China Biotech Services Holdings Headlines

No Headlines